地拉罗司分散片的效果

The therapeutic effect of Deferasirox (Enrige) is significant, the convenience is better, and the patient's compliance is higher. EPIC is currently the largest prospective, open, single-group, global multi-center clinical study designed for patients with iron overload. A total of 341 MDS patients were enrolled. After treatment, the experimental results showed that it could reduce serum ferritin by an average of 372 μg/L in 3 months. The results of a single-arm, multi-center, prospective clinical study enrolling 64 AA patients with transfusion-related iron overload confirmed the effectiveness and safety of deferasirox in reducing patients' ferritin levels.

Patients cannot blindly take this drug for treatment. Taking Deferasirox (Enrige) will also produce certain side effects or adverse reactions. The most common adverse reactions include: diarrhea/vomiting/headache/abdominal pain/fever/rash/increased serum creatinine, etc. Patients should undergo detailed examination before receiving deferasirox (Enrige) treatment and strictly follow the doctor's diagnosis and treatment recommendations.

Taking deferasirox (Enrige) for treatment may cause harm to the fetus, so patients should use effective contraception during treatment with this drug. Patients should inform their doctor if they are pregnant and take medication according to the doctor's diagnosis and treatment recommendations. If the patient is breastfeeding, he should stop breastfeeding immediately. Deferasirox (Enrige) may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dosage or stop taking the medication; however, patients should stop taking the medication if the condition is severe or persistent. Deferasirox (Enreg) should not be administered concurrently with aluminum-containing antacids. And deferasirox (Enrige) cannot be combined with other iron chelation treatments.

Deferasirox should be taken once daily on an empty stomach, at least 30 minutes before a meal, at the same time each day. Patients should not chew the tablets while taking this medicine. The method of using Deferasirox (Enrige) is also very important. It is recommended that patients use the drug under the guidance of a doctor based on their own condition.

The above is an introduction to the therapeutic effects of Deferasirox (Enrige). I hope it can help everyone. If patients have other questions about the drug (drug price, purchasing channels), they can consult the medical companion travel service.